Ratings for Hims & Hers Health (NYSE:HIMS) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Analysts’ evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.44, with a high estimate of $26.00 and a low estimate of $18.00. This upward trend is evident, with the current aver…